Lipid Testing Market – Strengthening Demand for Effective Drives Market

The Lipid Testing Market Is Growing With the Increasing Prevalence of Cardiovascular and Foodborne Diseases

Global Lipid Testing Market, by Technology (Recent and Traditional), by Application (Food & Beverages and Food Ingredients), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Industry Insights till 2025

Global Lipid Testing market for Food & Beverages was valued at US$ 833.4 million in 2016, according to Global Lipid Testing Market for Food & Beverages Report by Technology (Recent and Traditional), by Application (Food & Beverages and Food Ingredients). 

Market Overview:

Lipids are major source of energy, as they provide essential lipid nutrients. However, excessive consumption results in to various health complications. Lipids play diverse roles in the normal functioning of the body; they provide energy for living organisms and serve as the structural building material of all membranes of cells and organelles. Different lipids have different effects on the health. Trans and saturated fats appear to be bad for the health in large amounts.

Therefore, lipid testing is important; it measures multiple substances, including several types of cholesterol. Lipid test is used in both children and adults to evaluate risk of cardiovascular diseases, such as heart disease, stroke, and heart attack.

Request a sample copy of the report to understand the Market: 
https://www.coherentmarketinsights.com/insight/request-sample/1429

Competitive Landscape:

Key players active in the global lipid testing market are Bureau Veritas S.A., Ltd. TUV Nord Group, General Mills Inc., Campbell Brothers Limited, Eurofins Scientific SE, Intertek Group, AsureQuality Limited, and Microbac Laboratories Inc., among others.

Key Market Drivers:

Increasing incidence of cardiovascular diseases across the world is expected to augment the growth of the lipid testing market over the forecast period. For instance, according to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Heart attacks and strokes are very serious complications of cardiovascular disease that occur when heart arteries and brain arteries have a sudden blockage, respectively.

Moreover, increasing demand for lipid testing in the food industry due to increasing prevalence of foodborne diseases is expected to boost the growth of the lipid testing market. For instance, according to the Centers for Disease Control and Prevention (CDC), around 48 million people get sick, 128,000 are hospitalized, and 3,000 die from foodborne diseases each year in the U.S.

COVID-19 Impact Analysis:

Lipids are indispensable in the SARS-CoV-2 (COVID-19) infection process. The lipid profile should be considered as a sensitive marker of inflammation and should be measured in patients with COVID-19. Among patients hospitalized with COVID-19, LDL level below 50 mg/dL and triglycerides above 150 mg/dL are associated with increased odds for mortality. Moreover, the researchers also evaluated the association between lipid biomarkers and mortality among patients hospitalized with COVID-19. This in turn is expected to increase the demand for lipid testing worldwide, driving the market growth.

Key Takeaways

• The lipid testing market is expected to exhibit a CAGR of XX % during the forecast period owing to the stringent government regulations regarding food safety. For instance, Codex Alimentarius Commission (CAC), an international food standards body established jointly by WHO and the Food and Agriculture organization (FAO) with the objective of protecting consumer’s health and ensuring fair practices in food trade.
• Among regions, North America is expected to witness significant growth in the lipid testing market due to the increasing prevalence of cardiovascular diseases in this region. According to CDC, heart disease is the leading cause of death in the United States. Each year, around 655,000 people in the U.S. die from heart disease, that’s one in every four deaths.
• Asia Pacific is expected to witness significant growth in the lipid testing market owing to increasing prevalence of foodborne diseases in this region. Foodborne diseases are a major cause of illness and death. According to the Indian Journal of Public health, each year, an estimated 100 million foodborne illnesses and 120,000 foodborne illness-related deaths occur in India.

Great savings for you  2000$ Discount On Report:
https://www.coherentmarketinsights.com/insight/request-discount/1429

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com